New sites available now on Bearcats Landing

Visit the new sites launched on Bearcats Landing at my.uc.edu (UC login required)

UC Faculty and staff now have even more content to visit in Bearcats Landing, UC's intranet.

Visit the New Sites Launched (Spring Semester 2022) Bearcats Landing news article (UC Login required) to learn more about the following areas' new sites:


What is Bearcats Landing?

Bearcat mascot holding a sign that reads "My Bearcats Landing"; banner announcing "New sites launched"

Bearcats Landing is a desktop and mobile-friendly platform that develops and strengthens university-wide partnerships to support our future-facing evolution. It provides UC faculty and staff with the role-based tools and resources they need to increase communication and engagement.

Bearcats Landing is UC’s employee home base to read news and announcements, discover events and workshops, and find information essential to keeping the university running smoothly. It works to strengthen our professional community and capitalizes on our workplace diversity to empower individuals to be leaders in workplace. Even as our community grows more remote, we are still connected through the information-sharing and collaboration that takes place on Bearcats Landing.


Related Stories

2

Engineers develop deft solution to orient robots in space

March 11, 2026

To keep a repair robot stable while fixing satellites in space, University of Cincinnati engineers took a page from experts in balance: bull riders. UC College of Engineering and Applied Science graduate student James Talavage and Professor Ou Ma looked at simple but effective ways for a robot to maintain orientation while working on a broken satellite in zero gravity.

3

Study: Additional radiation for liver cancer does not increase toxicity

March 10, 2026

New research led by University of Cincinnati Cancer Center researchers published in the American Journal of Clinical Oncology found external beam radiation therapy (EBRT) is safe to administer to patients with liver cancer even after they undergo a targeted internal radiation therapy called Y90.